ATYR PHARMA INC (ATYR)

US0021202025 - Common Stock

3.29  0 (0%)

After market: 3.4168 +0.13 (+3.85%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
235.00K353.00K10.39M0.0010.46M
Minority Interest Expense
-1.00K8.00K5.00K9.00K6.00K
Operating Expenses
68.29M55.27M56.79M34.02M26.37M
Research and Development
54.90M42.29M42.81M23.26M17.29M
Selling, General, and Administrative Expenses
13.39M12.98M13.98M10.75M9.07M
Operating Income
-68.05M-54.92M-46.40M-34.02M-15.91M
Interest Income/Expense
N/AN/AN/AN/AN/A
Other Income/Expense
4.24M4.52M1.06M238.00K-319.00K
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-63.81M-50.40M-45.34M-33.78M-16.23M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-63.82M-50.39M-45.34M-33.77M-16.22M
EBITDA
-67.34M-54.33M-46.17M-33.54M-15.34M
 
Per Share Data
EPS Diluted Total Ops
-0.94-0.94-1.60-1.77-1.77
Non GAAP EPS
-0.94-0.96-1.60-1.88-1.59
 
Statistics
Profit Margin
-27155.74%-14274.50%-436.53%N/A-155.18%
Operating Profit Margin
-28958.72%-15557.79%-446.79%N/A-152.19%

All data in USD

Charts